Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study 6 months ago JohnIn Clinical TrialsStartups
Ultragenyx Gene Therapy Rejected by FDA Even as Takeda Scores Big in Narcolepsy Trial 8 months ago JohnIn Clinical TrialsFDA Approvals
FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug 8 months ago JohnIn Breaking NewsFDA Approvals
CSL Enters Major Partnership with VarmX to Advance Bleeding Management Drug 8 months ago JohnIn Biopharma HighlightsPartnerships
New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease 8 months ago JohnIn Breaking NewsBreakthroughsInnovationTop Stories
Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress 8 months ago JohnIn InvestmentsVenture Capital
New Regulatory Shift: NIH Requires Alternatives to Animal-Only Studies in Funded Research 8 months ago JohnIn Breaking NewsTop Stories
Strong Real-World Data Strengthens Case for Long-Acting HIV Injectables 8 months ago JohnIn Biopharma Highlights
4 FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug
